The original sins of clinical trials with intravenous immunoglobulins in sepsis.
about
Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and PathogensCommercial Intravenous Immunoglobulin (IVIg) Preparations Contain Functional Neutralizing Antibodies Against the Staphylococcus aureus Leukocidin LukAB (LukGH).Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study.The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure.A pro-inflammatory role of Fcα/μR on marginal zone B cells in sepsis.
P2860
The original sins of clinical trials with intravenous immunoglobulins in sepsis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The original sins of clinical trials with intravenous immunoglobulins in sepsis.
@en
type
label
The original sins of clinical trials with intravenous immunoglobulins in sepsis.
@en
prefLabel
The original sins of clinical trials with intravenous immunoglobulins in sepsis.
@en
P2093
P2860
P1433
P1476
The original sins of clinical trials with intravenous immunoglobulins in sepsis.
@en
P2093
David Andaluz-Ojeda
Eduardo Tamayo
Jesus F Bermejo-Martin
Jesús Blanco
Jose Ignacio Gomez-Herreras
Jose Maria Eiros
Leonor Nogales
Raquel Almansa
P2860
P2888
P356
10.1186/S13054-015-0793-0
P577
2015-02-26T00:00:00Z